261 related articles for article (PubMed ID: 27765068)
21. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas.
Machino H; Dozen A; Konaka M; Komatsu M; Nakamura K; Ikawa N; Shozu K; Asada K; Kaneko S; Yoshida H; Kato T; Nakayama K; Saloura V; Kyo S; Hamamoto R
Exp Mol Med; 2023 Oct; 55(10):2205-2219. PubMed ID: 37779141
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis.
Yi J; Wu M; Zheng Z; Zhou Q; Li X; Lu Y; Liu P
J Gynecol Oncol; 2023 Nov; 34(6):e71. PubMed ID: 37417299
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer.
Lund RJ; Huhtinen K; Salmi J; Rantala J; Nguyen EV; Moulder R; Goodlett DR; Lahesmaa R; Carpén O
Sci Rep; 2017 May; 7(1):1469. PubMed ID: 28473707
[TBL] [Abstract][Full Text] [Related]
24. BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
Rhyasen GW; Yao Y; Zhang J; Dulak A; Castriotta L; Jacques K; Zhao W; Gharahdaghi F; Hattersley MM; Lyne PD; Clark E; Zinda M; Fawell SE; Mills GB; Chen H
PLoS One; 2018; 13(7):e0200826. PubMed ID: 30036377
[TBL] [Abstract][Full Text] [Related]
25. Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Tsuchihashi H; Toji A; Ueda S; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Konishi H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731247
[No Abstract] [Full Text] [Related]
26. Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.
Jiménez-Sánchez A; Cybulska P; Mager KL; Koplev S; Cast O; Couturier DL; Memon D; Selenica P; Nikolovski I; Mazaheri Y; Bykov Y; Geyer FC; Macintyre G; Gavarró LM; Drews RM; Gill MB; Papanastasiou AD; Sosa RE; Soslow RA; Walther T; Shen R; Chi DS; Park KJ; Hollmann T; Reis-Filho JS; Markowetz F; Beltrao P; Vargas HA; Zamarin D; Brenton JD; Snyder A; Weigelt B; Sala E; Miller ML
Nat Genet; 2020 Jun; 52(6):582-593. PubMed ID: 32483290
[TBL] [Abstract][Full Text] [Related]
27. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
[TBL] [Abstract][Full Text] [Related]
28. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
Weigert M; Cui XL; West-Szymanski D; Yu X; Bilecz AJ; Zhang Z; Dhir R; Kehoe M; Zhang W; He C; Lengyel E
Gynecol Oncol; 2024 Mar; 182():82-90. PubMed ID: 38262243
[TBL] [Abstract][Full Text] [Related]
29. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
[TBL] [Abstract][Full Text] [Related]
30. Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma.
Brativnyk A; Ankill J; Helland Å; Fleischer T
Int J Cancer; 2024 Jul; 155(2):282-297. PubMed ID: 38489486
[TBL] [Abstract][Full Text] [Related]
31. OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN; Lewinger JP; Gooden G; Spillman M; Neuman M; Guo XM; Tew BY; Miller H; Khetan VU; Shulman LP; Roman L; Salhia B
Clin Cancer Res; 2023 Dec; 29(24):5196-5206. PubMed ID: 37812492
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.
Wilczyński J; Paradowska E; Wilczyńska J; Wilczyński M
Curr Oncol; 2023 Dec; 31(1):229-249. PubMed ID: 38248100
[TBL] [Abstract][Full Text] [Related]
33. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature.
Jung J; Lee CH; Seol HS; Choi YS; Kim E; Lee EJ; Rhee JK; Singh SR; Jun ES; Han B; Hong SM; Kim SC; Chang S
Oncotarget; 2016 Sep; 7(38):62533-62546. PubMed ID: 27613834
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
[TBL] [Abstract][Full Text] [Related]
35. Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse.
du Manoir S; Orsetti B; Bras-Gonçalves R; Nguyen TT; Lasorsa L; Boissière F; Massemin B; Colombo PE; Bibeau F; Jacot W; Theillet C
Mol Oncol; 2014 Mar; 8(2):431-43. PubMed ID: 24394560
[TBL] [Abstract][Full Text] [Related]
36. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Anselmino N; Labanca E; Shepherd PDA; Dong J; Yang J; Song X; Nandakumar S; Kundra R; Lee C; Schultz N; Zhang J; Araujo JC; Aparicio AM; Subudhi SK; Corn PG; Pisters LL; Ward JF; Davis JW; Vazquez ES; Gueron G; Logothetis CJ; Futreal A; Troncoso P; Chen Y; Navone NM
Clin Cancer Res; 2024 May; 30(10):2272-2285. PubMed ID: 38488813
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
Kong D; Wu Y; Liu Q; Huang C; Wang T; Huang Z; Gao Y; Li Y; Guo H
Eur J Med Res; 2024 Apr; 29(1):231. PubMed ID: 38609993
[TBL] [Abstract][Full Text] [Related]
38. Novel insights into the whole-blood DNA methylome of asthma in ethnically diverse children and youth.
Herrera-Luis E; Rosa-Baez C; Huntsman S; Eng C; Beckman KB; LeNoir MA; Rodriguez-Santana JR; Villar J; Laprise C; Borrell LN; Ziv E; Burchard EG; Pino-Yanes M
Eur Respir J; 2023 Dec; 62(6):. PubMed ID: 37802634
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide profiling of DNA methylome and transcriptome reveals epigenetic regulation of Urechis unicinctus response to sulfide stress.
Zhang W; Zhang L; Feng Y; Lin D; Yang Z; Zhang Z; Ma Y
Sci Total Environ; 2024 Jun; 927():172238. PubMed ID: 38582121
[TBL] [Abstract][Full Text] [Related]
40. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
